Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance

Transgenic Research

Volumn 23, Issue 3, 2014, Pages 519-529

  Vielnascher, Raimund M ^a   Hainzl, Eva ^a   Leitner, Nicole R ^a   Rammerstorfer, Michael ^a   Popp, David ^a   Witalisz, Agnieszka ^a   Rom, Rita ^a   Karaghiosoff, Marina ^a   Kolbe, Thomas ^a,b   Müller, Simone ^a   Rülicke, Thomas ^a   Lassnig, Caroline ^a   Strobl, Birgit ^a   Müller, Mathias ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Conditional knockout; JAK; Janus kinase; MC38; MCMV; Tumor transplant; Tyrosine kinase 2

Indexed keywords

PROTEIN KINASE TYK2; TYK2 PROTEIN, HUMAN;

ANIMAL; BIOSYNTHESIS; GENETICS; MOUSE; MUROMEGALOVIRUS; NEOPLASM; PATHOGENICITY; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; MICE; MICE, TRANSGENIC; MUROMEGALOVIRUS; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TYK2 KINASE;

EID: 84899974345     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-014-9795-y     Document Type: Article

References (46)

1. Aizu K, Li W, Yajima T, Arai T, Shimoda K, Nimura Y, Yoshikai Y (2006) An important role of Tyk2 in APC function of dendritic cells for priming CD8+ T cells producing IFN-gamma. Eur J Immunol 36: 3060-3070. doi: 10. 1002/eji. 200636173.
2. Babic M, Krmpotic A, Jonjic S (2011) All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol Med 17: 677-685. doi: 10. 1016/j. molmed. 2011. 07. 003.
3. Campbell AE, Cavanaugh VJ, Slater JS (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197: 205-213. doi: 10. 1007/s00430-008-0077-2.
4. Caton ML, Smith-Raska MR, Reizis B (2007) Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med 204: 1653-1664. doi: 10. 1084/jem. 20062648.
5. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B (2007) Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137. doi: 10. 1182/blood-2006-05-023770.
6. Cervantes-Barragan L, Kalinke U, Zust R, Konig M, Reizis B, Lopez-Macias C, Thiel V, Ludewig B (2009) Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol 182: 1099-1106.
7. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265-277. doi: 10. 1023/A: 1008942828960.
8. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439.
9. Eckelhart E, Warsch W, Zebedin E, Simma O, Stoiber D, Kolbe T, Rulicke T, Mueller M, Casanova E, Sexl V (2011) A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117: 1565-1573. doi: 10. 1182/blood-2010-06-291633.
10. Gu H, Zou YR, Rajewsky K (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73: 1155-1164. doi: 10. 1016/0092-8674(93)90644-6.
11. Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ, Darcy PK (2001) Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma. J Immunol 166: 182-187.
12. Hilburger Ryan M, Abrams SI (2001) Characterization of CD8+ cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant. Cancer Immunol Immunother 49: 603-612. doi: 10. 1007/s002620000156.
13. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, Merad M, Randolph GJ (2008) Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med 205: 2839-2850. doi: 10. 1084/jem. 20081430.
14. Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, McCoy B, Bogdan C, Decker T, Brem G, Pfeffer K, Muller M (2000) Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13: 549-560. doi: 10. 1016/S1074-7613(00)00054-6.
15. Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, Donabauer B, Reichart U, Kolbe T, Bogdan C, Leanderson T, Levy D, Decker T, Muller M (2003) Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4: 471-477. doi: 10. 1038/ni910.
16. Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL (2012) A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr 160: 1055-1057. doi: 10. 1016/j. jpeds. 2012. 01. 056.
17. Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, Tagaya Y (2005) Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105: 721-727. doi: 10. 1182/blood-2003-12-4187.
18. Krempler A, Qi Y, Triplett AA, Zhu J, Rui H, Wagner KU (2004) Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. Genesis 40: 52-57. doi: 10. 1002/gene. 20063.
19. Liang J, Tsui V, van Abbema A, Bao L, Barrett K, Beresini M, Berezhkovskiy L, Blair WS, Chang C, Driscoll J, Eigenbrot C, Ghilardi N, Gibbons P, Halladay J, Johnson A, Kohli PB, Lai Y, Liimatta M, Mantik P, Menghrajani K, Murray J, Sambrone A, Xiao Y, Shia S, Shin Y, Smith J, Sohn S, Stanley M, Ultsch M, Zhang B, Wu LC, Magnuson S (2013) Lead identification of novel and selective TYK2 inhibitors. Eur J Med Chem 67: 175-187. doi: 10. 1016/j. ejmech. 2013. 03. 070.
20. Melillo JA, Song L, Bhagat G, Blazquez AB, Plumlee CR, Lee C, Berin C, Reizis B, Schindler C (2010) Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol 184: 2638-2645. doi: 10. 4049/jimmunol. 0902960.
21. Miletic A, Krmpotic A, Jonjic S (2013) The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? Eur J Immunol 43: 867-877. doi: 10. 1002/eji. 201243101.
22. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755. doi: 10. 1016/j. immuni. 2006. 09. 009.
23. Mitrovic M, Arapovic J, Traven L, Krmpotic A, Jonjic S (2012) Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Med Microbiol Immunol 201: 487-495. doi: 10. 1007/s00430-012-0263-0.
24. Norman P (2012) Selective JAK1 inhibitor and selective Tyk2 inhibitor patents. Expert Opin Ther Pat 22: 1233-1249. doi: 10. 1517/13543776. 2012. 723693.
25. Orban PC, Chui D, Marth JD (1992) Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6861-6865. doi: 10. 1073/pnas. 89. 15. 6861.
26. Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho HI, Antonia S, Altiok S, Celis E, Gabrilovich DI (2010) Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J Clin Invest 120: 1111-1124. doi: 10. 1172/JCI40269.
27. Sacher T, Mohr CA, Weyn A, Schlichting C, Koszinowski UH, Ruzsics Z (2012) The role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol 91: 70-77. doi: 10. 1016/j. ejcb. 2011. 02. 002.
28. Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher M, Neuberg D, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CH, Weng AP, Staudt LM, Druker BJ, Look AT (2013) TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov 3: 564-577. doi: 10. 1158/2159-8290. CD-12-0504.
29. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675. doi: 10. 1038/nmeth. 2089.
30. Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081. doi: 10. 1093/nar/23. 24. 5080.
31. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS (2003) A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10. Q/J mice to infection and autoimmunity. Proc Natl Acad Sci USA 100: 11594-11599. doi: 10. 1073/pnas. 1930781100.
32. Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD (2006) Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res 26: 804-819. doi: 10. 1089/jir. 2006. 26. 804.
33. Shi J, Petrie HT (2012) Activation kinetics and off-target effects of thymus-initiated cre transgenes. PLoS ONE 7: e46590. doi: 10. 1371/journal. pone. 0046590.
34. Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, Nakayama K (2000) Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity 13: 561-571. doi: 10. 1016/S1074-7613(00)00055-8.
35. Simma O, Zebedin E, Neugebauer N, Schellack C, Pilz A, Chang-Rodriguez S, Lingnau K, Weisz E, Putz EM, Pickl WF, Felzmann T, Muller M, Decker T, Sexl V, Stoiber D (2009) Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance. Cancer Res 69: 203-211. doi: 10. 1158/0008-5472. CAN-08-1705.
36. Sohn SJ, Barrett K, van Abbema A, Chang C, Kohli PB, Kanda H, Smith J, Lai Y, Zhou A, Zhang B, Yang W, Williams K, Macleod C, Hurley CA, Kulagowski JJ, Lewin-Koh N, Dengler HS, Johnson AR, Ghilardi N, Zak M, Liang J, Blair WS, Magnuson S, Wu LC (2013) A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors. J Immunol 191: 2205-2216. doi: 10. 4049/jimmunol. 1202859.
37. Stockinger S, Kastner R, Kernbauer E, Pilz A, Westermayer S, Reutterer B, Soulat D, Stengl G, Vogl C, Frenz T, Waibler Z, Taniguchi T, Rulicke T, Kalinke U, Muller M, Decker T (2009) Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog 5: e1000355. doi: 10. 1371/journal. ppat. 1000355.
38. Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, Sexl V (2004) TYK2 is a key regulator of the surveillance of B lymphoid tumors. J Clin Invest 114: 1650-1658. doi: 10. 1172/JCI22315.
39. Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, Kolbe T, Karaghiosoff M, Kalinke U, Jonjic S, Muller M (2005) Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol 175: 4000-4008.
40. Strobl B, Stoiber D, Sexl V, Mueller M (2011) Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity. Front Biosci (Landmark Ed) 16: 3214-3232. doi: 10. 2741/3908.
41. Teppner I, Aigner B, Schreiner E, Muller M, Windisch M (2004) Polymorphic microsatellite markers in the outbred CFW and ICR stocks for the generation of speed congenic mice on C57BL/6 background. Lab Anim 38: 406-412. doi: 10. 1258/0023677041958882.
42. Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Forster I, Habenicht AJ, Reichardt HM, Tronche F, Schmid W, Schutz G (2007) Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117: 1381-1390. doi: 10. 1172/JCI28034.
43. Ubel C, Mousset S, Trufa D, Sirbu H, Finotto S (2013) Establishing the role of tyrosine kinase 2 in cancer. Oncoimmunology 2: e22840. doi: 10. 4161/onci. 22840.
44. Wallner B, Leitner NR, Vielnascher RM, Kernbauer E, Kolbe T, Karaghiosoff M, Rulicke T, Decker T, Muller M (2012) Generation of mice with a conditional Stat1 null allele. Transgenic Res 21: 217-224. doi: 10. 1007/s11248-011-9519-5.
45. Works MG, Song B, Kibler P, Tanga MJ, Galande AK, D'Andrea A (2013) Design of a peptide inhibitor of tyrosine kinase 2. Protein Pept Lett. doi: 10. 2174/0929866520666131203101841.
46. Zhang Q, Sturgill JL, Kmieciak M, Szczepanek K, Derecka M, Koebel C, Graham LJ, Dai Y, Chen S, Grant S, Cichy J, Shimoda K, Gamero A, Manjili M, Bear H, Conrad D, Larner AC (2011) The role of Tyk2 in regulation of breast cancer growth. J Interferon Cytokine Res 31: 671-677. doi: 10. 1089/jir. 2011. 0023.